Researchers at the University of California San Diego in the US collected about 619,937 tweets containing the keywords codeine, Percocet, fentanyl, Vicodin, Oxycontin, oxycodone and hydrocodone.
They detected 1,778 posts that were marketing the sale of controlled substances, 90 per cent included hyperlinks to online sites for purchase.
"An unhealthy use of prescription and non-prescription opioid drugs continues to rise in the US. Public policy and law enforcement efforts are trying to address this crisis, but closer attention to the potential negative influence of digital technologies is needed," said Tim K Mackey, associate professor at UC San Diego School of Medicine.
Researchers used a three-step process that involved cloud-based computing to collect large volumes of tweets filtered by keywords, machine learning to isolate tweets related to the marketing of opioids, and web forensic examination to analyse posts that included hyperlinks to external websites.
During the five-month study period, less than one per cent of tweets mentioning opioids were marketing prescription opioids, and only 46 of the hyperlinks included in those tweets were still live when the team analysed the data eight months later.
"Social media providers can use it to find or prohibit content that is illegal or violates laws to ensure consumers have a safer experience online," he said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
